Existing research results have indicated that ER- and PR- breast cancers tend to a worse prognosis than ER+ or PR+ breast cancers, while ER+ and PR+ tumors are well differentiated and less aggressive to a large extent (30). The gene discussed is ESR1; the disease is breast cancer.